New drug targets tough cancers in early trial
NCT ID NCT06597721
First seen Oct 31, 2025 · Last updated May 11, 2026 · Updated 27 times
Summary
This early-phase study tests a new drug called ADCE-T02 in people with advanced solid tumors that have not responded to other treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. The main goals are to find the safest dose and understand side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cabrini Hospital
RECRUITINGMalvern, Victoria, 3144, Australia
-
Highlands Oncology Group
RECRUITINGRogers, Arkansas, 72758, United States
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Macquarie University Hospital
RECRUITINGMacquarie Park, New South Wales, 2109, Australia
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Peninsula and South Eastern Haematology and Oncology Group (PSEHOG)
RECRUITINGFrankston, Victoria, 3199, Australia
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
-
Yale University Cancer Center
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.